Atlas Trials

Multicenter, Prospective, Observational Study on the Treatment of Type 2 Diabetes With Proline Plus Empagliflozin Tablets

Clinical trial NCT07023172 · RECRUITING

Trial details

NCT number
NCT07023172
Sponsor
The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School
Status
RECRUITING
Study type
OBSERVATIONAL
Type 2 Diabetes
Start date
2025-05-30
Primary completion
2027-10-01
Enrollment
3000

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.